June 18, 2026 · Obstetrics and gynecology · DOI: 10.1097/AOG.0000000000006354

Association of Respiratory Syncytial Virus Vaccination During Pregnancy With Adverse Obstetric and Neonatal Outcomes

Listen to this summary

The authors aimed to evaluate the safety of the bivalent prefusion F subunit-based respiratory syncytial virus vaccine (RSVpreF) during pregnancy, specifically assessing its association with adverse obstetric and neonatal outcomes. Their findings indicate that while there was no significant increase in risks for preterm birth, stillbirth, or small-for-gestational-age birth weight among vaccinated patients, there was a statistically significant increase in the risk of hypertensive disorders of pregnancy. Overall, the study suggests a largely favorable safety profile for the RSVpreF vaccine in pregnant individuals.

Malini DeSilva, Jacob Haapala, Elyse O Kharbanda, Kimberly K Vesco, Matthew F Daley, Darios Getahun, Katharine Raisler, Allison L Naleway, Lisa A Jackson, Joshua T B Williams, Nicola P Klein, Karen B Jacobson, Sarah Jorgensen, Brian E Dixon, Candace C Fuller, Eric S Weintraub, Elizabeth M Quincer, Heather S Lipkind, Gabriela Vazquez-Benitez

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play